Lipid emulsion 20%
Local anesthetic systemic toxicity (LAST) - off-label, guideline-based, Labeled use: parenteral nutrition source of calories/essential fatty acids
Indications
- Local anesthetic systemic toxicity (LAST) - off-label, guideline-based
- Labeled use: parenteral nutrition source of calories/essential fatty acids
Adult dosing
- last bolus over 70kg: dose: 100; unit: mL; route: IV - lipid injectable emulsion 20% (Intralipid 20%, 0.2 g/mL); interval: over 2-3 min; repeat bolus (or double infusion) if still unstable; fixed: true; guideline: ASRA Checklist for Treatment of LAST, 2020 (patients >70 kg); evidence: asra-last
- last infusion over 70kg: dose: 250; unit: mL; route: IV - lipid injectable emulsion 20% (Intralipid 20%, 0.2 g/mL); interval: over 15-20 min; fixed: true; guideline: ASRA Checklist for Treatment of LAST, 2020 (patients >70 kg); evidence: asra-last
Pediatric dosing
- last bolus 70kg or less: dose: 1.5; unit: mL/kg; route: IV - lipid injectable emulsion 20% (Intralipid 20%, 0.2 g/mL); interval: over 2-3 min (lean body weight); maximum lipid dose 12 mL/kg total; weightBased: false; pedNote: No label-stated per-dose maximum verified; weight-based calculation disabled. Consult pharmacy/current label.; guideline: ASRA Checklist for Treatment of LAST, 2020 (patients <70 kg); evidence: asra-last
- last infusion 70kg or less: dose: 0.25; unit: mL/kg/min; route: IV - lipid injectable emulsion 20% (Intralipid 20%, 0.2 g/mL); interval: maximum lipid dose 12 mL/kg total; weightBased: true; maxDose: 0.5; titrationTarget: Titrate to effect: double infusion rate if still unstable (ASRA); guideline: ASRA Checklist for Treatment of LAST, 2020 (patients <70 kg); evidence: asra-last
Renal adjustment
- Consult pharmacy/current label
Hepatic adjustment
- Consult pharmacy/current label
Contraindications
- Known hypersensitivity to egg, soybean, peanut
- Severe disorders of lipid metabolism (triglyceride > 1,000 mg/dL)
Clinical pearls
- FDA label is for parenteral nutrition only; LAST dosing below is guideline-based (ASRA 2020), not label-derived
- Stop or reduce propofol; propofol is not a substitute for 20% lipid emulsion
- Use 1.2 micron in-line filter for administration.
- Monitor serum triglycerides and liver function tests regularly.
- Strictly adhere to the maximum infusion rate (0.75 mL/kg/hour in pediatrics; 0.5 mL/kg/hour in adults).
- Risk of fat overload syndrome and parenteral nutrition-associated liver disease (PNALD).
Source and review
- DailyMed label (i.v. fat emulsion, Intralipid), Set ID 48c12fbe-c5e8-a1fc-e063-6294a90a15ae, effective 2026-01-19; ASRA Checklist for Treatment of LAST, 2020 (patients >70 kg); ASRA Checklist for Treatment of LAST, 2020 (patients <70 kg). Last reviewed: 2026-11-11
RotationRx · Drugs · Scores · Protocols · Diagnoses · Specialties